Skip to content
Home/Companies/MedTech/Dreampath Diagnostics
Dreampath Diagnostics

Dreampath Diagnostics

MedTech·USA·Active
Entry
–
Hold
–
Status
Active

Who owns Dreampath Diagnostics?

Dreampath Diagnostics is an American MedTech company, currently owned by Summit Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Summit Partners
Investor
Summit Partners
Summit Partners Growth Equity Fund XII · 2024 · Growth

Key facts

HQUSA
SectorMedTech
Websitedreampathdx.net

More from Summit Partners Growth Equity Fund XII

Other portfolio companies in the same fund.

Access Information Management
Access Information Management
Active
Business ServicesUS
Aurora Diagnostics
Active
HealthcareUS
Belkin International
Belkin International
Active
TMTUS
Bluepearl Veterinary Services
Active
HealthcareUS
Cardiovascular Provider Resource
Active
HealthcareUS
Celcoin
Celcoin
Active
FintechUS

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Dreampath Diagnostics?

Dreampath Diagnostics is currently owned by Summit Partners, through Summit Partners Growth Equity Fund XII.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue